Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

The objective of this study was to compare the efficacy of biomarkers in assessing the risk of breast cancer recurrence in patients with node-negative or micrometastatic grade II breast cancer. | Assessment of Ki67 and uPA PAI-1 expression in intermediate-risk early stage breast cancers

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN